These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34951366)

  • 61. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
    Hook G; Hook V; Kindy M
    J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells.
    Liu H; Li Z; Qiu D; Gu Q; Lei Q; Mao L
    Neurosci Lett; 2010 Nov; 485(2):83-8. PubMed ID: 20727383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Kulnane LS; Younkin L; Younkin S; Evin G; Lamb BT
    J Biol Chem; 2004 Dec; 279(50):52535-42. PubMed ID: 15452128
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.
    Adwan L; Subaiea GM; Zawia NH
    Neuropharmacology; 2014 Apr; 79():596-602. PubMed ID: 24462621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SUMO1 modulates Aβ generation via BACE1 accumulation.
    Yun SM; Cho SJ; Song JC; Song SY; Jo SA; Jo C; Yoon K; Tanzi RE; Choi EJ; Koh YH
    Neurobiol Aging; 2013 Mar; 34(3):650-62. PubMed ID: 22975420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuronal human BACE1 knockin induces systemic diabetes in mice.
    Plucińska K; Dekeryte R; Koss D; Shearer K; Mody N; Whitfield PD; Doherty MK; Mingarelli M; Welch A; Riedel G; Delibegovic M; Platt B
    Diabetologia; 2016 Jul; 59(7):1513-1523. PubMed ID: 27138913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation.
    Maesako M; Uemura M; Tashiro Y; Sasaki K; Watanabe K; Noda Y; Ueda K; Asada-Utsugi M; Kubota M; Okawa K; Ihara M; Shimohama S; Uemura K; Kinoshita A
    PLoS One; 2015; 10(9):e0131199. PubMed ID: 26414661
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
    Kizuka Y; Kitazume S; Fujinawa R; Saito T; Iwata N; Saido TC; Nakano M; Yamaguchi Y; Hashimoto Y; Staufenbiel M; Hatsuta H; Murayama S; Manya H; Endo T; Taniguchi N
    EMBO Mol Med; 2015 Feb; 7(2):175-89. PubMed ID: 25592972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BACE1 in Alzheimer's disease.
    Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
    Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
    Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carbon monoxide attenuates amyloidogenesis via down-regulation of NF-κB-mediated BACE1 gene expression.
    Kim HJ; Joe Y; Chen Y; Park GH; Kim UH; Chung HT
    Aging Cell; 2019 Feb; 18(1):e12864. PubMed ID: 30411846
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS.
    Georgievska B; Gustavsson S; Lundkvist J; Neelissen J; Eketjäll S; Ramberg V; Bueters T; Agerman K; Juréus A; Svensson S; Berg S; Fälting J; Lendahl U
    J Neurochem; 2015 Feb; 132(4):477-86. PubMed ID: 25156639
    [TBL] [Abstract][Full Text] [Related]  

  • 75. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
    Long JM; Ray B; Lahiri DK
    J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.
    Miyamoto M; Kuzuya A; Noda Y; Ueda S; Asada-Utsugi M; Ito S; Fukusumi Y; Kawachi H; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2020; 75(1):173-185. PubMed ID: 32280101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
    Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
    Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice.
    Meakin PJ; Jalicy SM; Montagut G; Allsop DJP; Cavellini DL; Irvine SW; McGinley C; Liddell MK; McNeilly AD; Parmionova K; Liu YR; Bailey CLS; Dale JK; Heisler LK; McCrimmon RJ; Ashford MLJ
    Sci Rep; 2018 Jan; 8(1):55. PubMed ID: 29311632
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
    Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
    Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.